Related Experiment Video
Updated: Feb 28, 2026

Bile Salt-induced Biofilm Formation in Enteric Pathogens: Techniques for Identification and Quantification
Published on: May 6, 2018
Matrix exopolysaccharides; the sticky side of biofilm formation
1Department of Biochemistry, University of Cambridge, Tennis Court Road, Hopkins Building, Cambridge CB2 1QW, UK. Tel: +44 01223 333653;
Abstract:
The Gram-negative pathogen Pseudomonas aeruginosa is found ubiquitously within the environment and is recognised as an opportunistic human pathogen that commonly infects burn wounds and immunocompromised individuals, or patients suffering from the autosomal recessive disorder cystic fibrosis (CF). During chronic infection, P. aeruginosa is thought to form structured aggregates known as biofilms characterised by a self-produced matrix which encases the bacteria, protecting them from antimicrobial attack and the host immune response. In many cases, antibiotics are ineffective at eradicating P. aeruginosa from chronically infected CF airways. Cyclic-di-GMP has been identified as a key regulator of biofilm formation; however, the way in which its effector proteins elicit a change in biofilm formation remains unclear. Identifying regulators of biofilm formation is a key theme of current research and understanding the factors that activate biofilm formation may help to expose potential new drug targets that slow the onset of chronic infection. This minireview outlines the contribution made by exopolysaccharides to biofilm formation, and describes the current understanding of biofilm regulation in P. aeruginosa with a particular focus on CF airway-associated infections.
Insights
Pseudomonas aeruginosa forms protective biofilms in cystic fibrosis (CF) patients, hindering antibiotic treatment. Understanding biofilm regulation, particularly exopolysaccharide roles, may reveal new therapeutic targets.
Area of Science:
- Microbiology
- Infectious Diseases
- Biochemistry
Background:
- * Pseudomonas aeruginosa is an opportunistic pathogen frequently causing chronic infections in cystic fibrosis (CF) patients.
- * Biofilms protect P. aeruginosa from antibiotics and host immunity, making eradication difficult in CF airways.
- * Cyclic-di-GMP is a known regulator of biofilm formation, but its downstream effectors remain poorly understood.
Purpose of the Study:
- * To review the role of exopolysaccharides in P. aeruginosa biofilm development.
- * To summarize current knowledge on P. aeruginosa biofilm regulation, focusing on CF infections.
- * To highlight potential new drug targets for combating chronic P. aeruginosa infections.
Main Methods:
- * Literature review of studies on P. aeruginosa biofilm formation.
- * Analysis of the regulatory mechanisms controlling biofilm development.
- * Focus on exopolysaccharide contributions and cyclic-di-GMP signaling pathways.
Main Results:
- * Exopolysaccharides are crucial components of the P. aeruginosa biofilm matrix.
- * Cyclic-di-GMP signaling influences biofilm architecture and stability.
- * Specific regulatory pathways controlling biofilm formation are being elucidated.
Conclusions:
- * Elucidating biofilm regulatory networks is critical for developing effective treatments.
- * Targeting exopolysaccharide synthesis or regulation could be a viable therapeutic strategy.
- * Further research into P. aeruginosa biofilm formation is essential for managing chronic infections in CF.
More Related Videos
12:58In Situ Mapping of the Mechanical Properties of Biofilms by Particle-tracking Microrheology
Published on: December 4, 2015
12:02Automated Modular High Throughput Exopolysaccharide Screening Platform Coupled with Highly Sensitive Carbohydrate Fingerprint Analysis
Published on: April 11, 2016
Related Concept Videos
Biofilms
Formation of Lipopolysaccharides
Glycocalyx and its Functions
Outer Layers of the Cell Envelope
Matrix Proteoglycans and Glycoproteins
Cellulose and Pectic Polysaccharides
As a cell matures, its cell wall specializes according to its type. For example, the...